Q1 EPS Forecast for Phibro Animal Health Raised by Analyst

Key Points

• Analysts at Zacks Research have raised their Q1 2026 earnings per share (EPS) estimate for Phibro Animal Health to $0.33, up from $0.32, while also projecting a full-year EPS of $1.95.
• The company has seen several upgrades from brokerages, with JPMorgan Chase & Co. increasing their price target significantly from $25.00 to $35.00.
• Phibro Animal Health recently declared a quarterly dividend of $0.12 per share, representing an annualized yield of 1.5% and a payout ratio of 61.54%.

Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) - Stock analysts at Zacks Research upped their Q1 2026 EPS estimates for shares of Phibro Animal Health in a report issued on Tuesday, August 19th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $0.33 for the quarter, up from their prior estimate of $0.32. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health's Q2 2026 earnings at $0.60 EPS, Q3 2026 earnings at $0.61 EPS, FY2026 earnings at $2.21 EPS and FY2027 earnings at $2.35 EPS.

A number of other brokerages also recently issued reports on PAHC. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target on the stock in a research report on Monday, June 16th. Morgan Stanley set a $26.00 price target on shares of Phibro Animal Health and gave the stock an "equal weight" rating in a research report on Wednesday, June 25th. Finally, JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and boosted their price target for the stock from $25.00 to $35.00 in a research report on Monday, July 7th. One research analyst has rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Phibro Animal Health presently has an average rating of "Reduce" and a consensus target price of $24.40.

Phibro Animal Health Trading Up 1.9%

PAHC opened at $31.85 on Wednesday. Phibro Animal Health has a fifty-two week low of $16.16 and a fifty-two week high of $32.08. The company has a debt-to-equity ratio of 2.67, a current ratio of 2.91 and a quick ratio of 1.23. The firm has a market capitalization of $1.29 billion, a price-to-earnings ratio of 40.83, a PEG ratio of 0.52 and a beta of 0.80. The company's 50 day moving average price is $27.86 and its two-hundred day moving average price is $23.92.

Institutional Trading of Phibro Animal Health

A number of hedge funds and other institutional investors have recently bought and sold shares of PAHC. Geode Capital Management LLC grew its stake in shares of Phibro Animal Health by 1.7% in the 4th quarter. Geode Capital Management LLC now owns 515,979 shares of the company's stock worth $10,838,000 after acquiring an additional 8,510 shares in the last quarter. Wells Fargo & Company MN grew its stake in shares of Phibro Animal Health by 1.5% in the 4th quarter. Wells Fargo & Company MN now owns 149,678 shares of the company's stock worth $3,143,000 after acquiring an additional 2,247 shares in the last quarter. Envestnet Asset Management Inc. bought a new stake in shares of Phibro Animal Health in the 4th quarter worth $219,000. Russell Investments Group Ltd. grew its stake in shares of Phibro Animal Health by 86.5% in the 4th quarter. Russell Investments Group Ltd. now owns 15,115 shares of the company's stock worth $317,000 after acquiring an additional 7,011 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Phibro Animal Health in the 4th quarter worth $1,103,000. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 24th. Shareholders of record on Wednesday, September 3rd will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date is Wednesday, September 3rd. Phibro Animal Health's payout ratio is 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.